<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Jambor, Ivan</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">IMPROD: Biparametric MRI Effective in Detecting Prostate Cancer</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-02-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">10-10</style></pages><abstract><style  face="normal" font="default" size="100%">The Improved Prostate Cancer Diagnosis–Combination of Magnetic Resonance Imaging and Biomarkers trial [IMPROD; NCT01864135] was designed to assess the accuracy of a biparametric magnetic resonance imaging approach and targeted biopsy for patients suspected of having prostate cancer based on digital rectal examination or an elevated prostate-specific antigen value &gt; 2.5 ng/mL. This article discusses the preliminary results.</style></abstract><number><style face="normal" font="default" size="100%">53</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>